Trial
NCT01791465
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Human Immunodeficiency Virus Infection
Intervention
extended-release exenatide
Why stopped
This study was terminated after 6 patients due to loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-10